33 min listen
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
ratings:
Length:
21 minutes
Released:
Oct 25, 2021
Format:
Podcast episode
Description
In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.
Released:
Oct 25, 2021
Format:
Podcast episode
Titles in the series (100)
September 11 2007 Issue: Mediterranean Diet and Alzheimer Disease Mortality by Neurology® Podcast